- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02317328
Imágenes retinales de óptica adaptativa
Background:
- By the time diseases of the retina are detected, serious damage has often already been done. Researchers want to find better ways of viewing the retina. One way called adaptive optics may help detect problems earlier.
Objectives:
- To study if adaptive optics can help find better ways to diagnose, treat, and manage retinal diseases.
Eligibility:
- People over age 12 with an eye disease.
- Healthy volunteers over age 12.
Design:
- Participants will be screened with medical history and eye exams. These may include dilating pupils and taking pictures of the eyes.
- Participants will have 1 or more study visits. They will have:
- Medical and eye history.
- Questions about their medications.
- Eye exam including pupil dilation.
- Adaptive optics imaging. After dilation, participants sit still while looking into an adaptive optics instrument. They look at specific places and images are taken of their retina.
- They may also have:
- More images.
- Perimetry. Participants look into a lens and press a button when they see a light.
- Color vision tests.
- Electroretinogram. Participants will get numbing eye drops and special contact lenses. A small metal electrode will be put on their forehead. They will look at flashing lights and try not to blink.
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Objective: The objective of this protocol is to collect and assess adaptive optics (AO) retinal images of normal and diseased eyes.
Study Population: Three hundred and fifty (350) participants with eye diseases and 250 normal volunteers will be enrolled.
Design: This is an observational protocol which will enroll 350 participants with various eye diseases and 250 age-matched healthy volunteers over five years. In general, participants will undergo a complete ophthalmic examination including assessments of visual acuity, intraocular pressure, and a dilated ocular examination. Imaging will be performed using adaptive optics instruments deployed in the NEI Eye Clinic.
Outcome Measures: The primary outcome for this protocol is qualitative and quantitative assessment of the AO images with comparisons of normal and diseased states.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Daniel W Claus, R.N.
- Número de teléfono: (301) 451-1621
- Correo electrónico: daniel.claus@nih.gov
Copia de seguridad de contactos de estudio
- Nombre: Johnny C Tam, Ph.D.
- Número de teléfono: (301) 435-7821
- Correo electrónico: johnny.tam@nih.gov
Ubicaciones de estudio
-
-
Maryland
-
Bethesda, Maryland, Estados Unidos, 20892
- Reclutamiento
- National Institutes of Health Clinical Center
-
Contacto:
- For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
- Número de teléfono: TTY dial 711 800-411-1222
- Correo electrónico: ccopr@nih.gov
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
500 participants with eye diseases and 500 healthy volunteers will be enrolled.
Descripción
- INCLUSION CRITERIA:
Participants will be eligible if they:
- Are 12 years of age or older.
- Have the ability to cooperate with an eye exam and adaptive optics imaging.
- Have the ability to understand and sign an informed consent or have a parent/legal guardian to do so if they are minor children.
- Have an eye disease or are a healthy volunteer with a normal eye exam (no visually-significant eye findings on examination).
EXCLUSION CRITERIA:
Participants will not be eligible if:
-They have a condition which prevents adequate images from being obtained (e.g. unstable fixation or media opacity).
EXCLUSION CRITERIA FOR FLUORESCEIN AND/OR INDOCYANINE GREEN IMAGING
Partaicipants are not eligible for fluorescein and/or indocyanine green imaging if they:
- Are under 18 years of age.
- For participants who will undergo fluorescein imaging have a history of adverse reaction to fluorescein.
- For participants who will undergo indocyanine green imaging have a history of adverse reaction to indocyanine green dye, know or suspected allergies to iodine or shellfish.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: CASE_CONTROL
- Perspectivas temporales: CROSS_SECTIONAL
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Healthy Volunteers
Healthy volunteers |
|
Affected participants
Participants with ocular conditions |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Qualitative and quantitative assessment of AO images
Periodo de tiempo: ongoing
|
Qualitative and quantitative assessment of AO images with comparison of normal and diseased states. |
ongoing
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Johnny C Tam, Ph.D., National Eye Institute (NEI)
Publicaciones y enlaces útiles
Publicaciones Generales
- Hendrickson A, Drucker D. The development of parafoveal and mid-peripheral human retina. Behav Brain Res. 1992 Jul 31;49(1):21-31. doi: 10.1016/s0166-4328(05)80191-3.
- Wing GL, Blanchard GC, Weiter JJ. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1978 Jul;17(7):601-7.
- Fotedar R, Wang JJ, Burlutsky G, Morgan IG, Rose K, Wong TY, Mitchell P. Distribution of axial length and ocular biometry measured using partial coherence laser interferometry (IOL Master) in an older white population. Ophthalmology. 2010 Mar;117(3):417-23. doi: 10.1016/j.ophtha.2009.07.028. Epub 2010 Jan 19.
Enlaces Útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimado)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 150020
- 15-EI-0020
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .